ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+7.88%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$76.3M
AUM Growth
+$76.3M
(-26%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-31.5%
Top 10 Holdings %
Top 10 Hldgs %
86.7%
Holding
43
New
13
Increased
–
Reduced
2
Closed
25
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$9.79M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$9.55M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$8.15M |
| 4 |
Cytokinetics
CYTK
|
$7.86M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$7.17M |
Top Sells
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$8.58M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$8.12M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$7.56M |
| 4 |
Galapagos
GLPG
|
$6.22M |
| 5 |
ALLK
Allakos
ALLK
|
$5.24M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
1
Verona Pharma
VRNA
$9.16B
| $9.79M | 12.83% | +487,631 | New | +$9.79M |
|
|
2
Xenon Pharmaceuticals
XENE
$2.98B
| $9.55M | 12.52% | +266,961 | New | +$9.55M |
|
|
BLU
3
DELISTED
BELLUS Health Inc.
BLU
| $8.15M | 10.68% | +1,131,827 | New | +$8.15M |
|
|
4
Cytokinetics
CYTK
$4.23B
| $7.86M | 10.3% | +223,382 | New | +$7.86M |
|
|
5
Madrigal Pharmaceuticals
MDGL
$9.76B
| $7.17M | 9.4% | +29,614 | New | +$7.17M |
|
|
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.21M | 8.14% | +255,310 | New | +$6.21M |
|
7
Merus
MRUS
$4.98B
| $5.08M | 6.66% | +275,970 | New | +$5.08M |
|
8
Mersana Therapeutics
MRSN
$36.5M
| $4.9M | 6.42% | 1,191,271 | – | – |
|
9
Jasper Therapeutics
JSPR
$45.5M
| $4.56M | 5.97% | +2,517,232 | New | +$4.56M |
|
10
Sarepta Therapeutics
SRPT
$1.78B
| $2.87M | 3.76% | +20,830 | New | +$2.87M |
|
|
CTIC
11
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.31M | 3.03% | +550,000 | New | +$2.31M |
|
|
MDVL
12
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $1.69M | 2.21% | 5,894,897 | – | – |
|
13
MDxHealth
MDXH
$176M
| $1.62M | 2.12% | +500,000 | New | +$1.62M |
|
14
MoonLake Immunotherapeutics
MLTX
$3.54B
| $1.56M | 2.04% | +72,850 | New | +$1.56M |
|
15
Rapid Micro Biosystems
RPID
$107M
| $917K | 1.2% | 699,664 | – | – |
|
16
ESSA Pharma
EPIX
$11.4M
| $703K | 0.92% | 236,583 -574,972 | -71% | -$1.71M |
|
|
KNTE
17
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $684K | 0.9% | +109,393 | New | +$684K |
|
|
SYRS
18
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $665K | 0.87% | 249,126 -619,277 | -71% | -$1.65M |
|
19
Alkermes
ALKS
$4.78B
| – | – | -142,002 | Closed | -$3.71M |
|
|
ALLK
20
DELISTED
Allakos
ALLK
| – | – | -622,364 | Closed | -$5.24M |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| – | – | -3,730,859 | Closed | -$4.51M |
|
22
Atea Pharmaceuticals
AVIR
$267M
| – | – | -962,694 | Closed | -$4.63M |
|
23
Biohaven
BHVN
$1.63B
| – | – | -179,085 | Closed | -$2.49M |
|
24
Curis
CRIS
$20.9M
| – | – | -827,397 | Closed | -$455K |
|
25
Denali Therapeutics
DNLI
$2.23B
| – | – | -4,479 | Closed | -$125K |
|